Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lonapegsomatropin

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TransCon hGH Matches Somatropin in InsiGHTS Turner Trial
    TransCon hGH Matches Somatropin in InsiGHTS Turner Trial

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257185/0/en/New-InsiGHTS-Trial-of-TransCon-hGH-Lonapegsomatropin-in-Turner-Syndrome-Demonstrated-Comparable-Efficacy-and-Safety-to-Daily-Somatropin-at-Week-52.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Ascendis Presents Endocrinology Rare Disease Data at ASBMR 2025
    Ascendis Presents Endocrinology Rare Disease Data at ASBMR 2025

    02 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/02/3143121/0/en/Ascendis-to-Share-Latest-Endocrinology-Rare-Disease-Data-in-3-Oral-Presentations-at-ASBMR-2025.html

    GLOBENEWSWIRE
    02 Sep 2025
    Share Share
    Ascendis's Biologics Skytrofa Receives Suppl Approval in US
    Ascendis's Biologics Skytrofa Receives Suppl Approval in US

    25 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761177

    FDA
    25 Jul 2025
    Share Share
    Ascendis`s Biologics Skytrofa Receive Suppl Approval in US
    Ascendis`s Biologics Skytrofa Receive Suppl Approval in US

    09 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761177

    FDA
    09 Jul 2025
    Share Share
    TransCon CNP Shows Gains in Achondroplasia at Week 26
    TransCon CNP Shows Gains in Achondroplasia at Week 26

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095728/0/en/TransCon-hGH-Boosted-Treatment-Benefits-of-TransCon-CNP-in-Children-with-Achondroplasia-at-Week-26-Interim-Analysis-of-the-Phase-2-COACH-Trial.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share
    New Therapy for Children with Growth Hormone Deficiency Approved
    New Therapy for Children with Growth Hormone Deficiency Approved

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-therapy-for-children-with-growth-hormone-deficiency-approved-in-australia-302468041.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.